A Research Study for Patients With Overactive Bladder

• Status: Completed
• Trial end date: 2008-06-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to investigate whether injections of botulinum toxin Type A into the bladder are safe and effective in treating overactive bladder.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Allergan
• Treatments: abobotulinumtoxinA; Botulinum Toxins; Botulinum Toxins, Type A; incobotulinumtoxinA; onabotulinumtoxinA

Criteria

Inclusion Criteria:

• Must be between 18-85 years old

• Must have been diagnosed by his/her doctor with overactive bladder at least 6 months ago

• Must weigh at least 50 kg (110 lbs)

• Must be willing and able to record information regarding bladder function into a diary (provided)

• Must be willing and able to complete the entire course of the study

Exclusion Criteria:

• Cannot currently be catheterizing as a way to control incontinence

• Must not have used botulinum toxin type A or any other botulinum toxin previously for any condition